High-resolution profiling of fetal DNA clearance from maternal plasma by massively parallel sequencing

Clinical Chemistry

Volumn 59, Issue 8, 2013, Pages 1228-1237

  Yu, Stephanie C Y ^a,b   Lee, Shara W Y ^a,b   Jiang, Peiyong ^a,b   Leung, Tak Y ^a   Chan, K C Allen ^a,b   Chiu, Rossa W K ^a,b   Lo, Y M Dennis ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DNA FRAGMENT; FETAL DNA; UNCLASSIFIED DRUG;

ARTICLE; BLOOD SAMPLING; CESAREAN SECTION; CLEARANCE; CLINICAL ARTICLE; DNA DETERMINATION; DNA SEQUENCE; FETUS; GENOTYPE; HUMAN; MASSIVELY PARALLEL SEQUENCING; MATERNAL PLASMA; PREGNANCY; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; UMBILICAL CORD BLOOD; URINALYSIS; URINARY EXCRETION;

BIRTH WEIGHT; CESAREAN SECTION; DNA; FEMALE; FETUS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; KINETICS; POSTPARTUM PERIOD; PREGNANCY; TIME FACTORS;

EID: 84880863124     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2013.203679     Document Type: Article

References (37)

1. Lo YMD, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, Wainscoat JS. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485-7.
2. Faas BH, Beuling EA, Christiaens GC, von dem Borne AE, van der Schoot CE. Detection of fetal RHD-specific sequences in maternal plasma. Lancet 1998;352:1196.
3. Lo YMD, Hjelm NM, Fidler C, Sargent IL, Murphy MF, Chamberlain PF, et al. Prenatal diagnosis of fetal RHD status by molecular analysis of maternal plasma. N Engl J Med 1998;339:1734-8.
4. Finning K, Martin P, Summers J, Massey E, Poole G, Daniels G. Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RHD immunoglobulin in RHD negative pregnant women: prospective feasibility study. BMJ 2008;336:816-8.
5. Chiu RWK, Akolekar R, Zheng YW, Leung TY, Sun H, Chan KCA, et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ 2011;342:c7401.
6. Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich M, et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011;13:913-20.
7. Palomaki GE, Deciu C, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med 2012;14:296-305.
8. Bianchi DW, Platt LD, Goldberg JD, Abuhamad AZ, Sehnert AJ, Rava RP, et al. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012;119:890-901.
9. Lo YMD, Zhang J, Leung TN, Lau TK, Chang AM, Hjelm NM. Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 1999;64:218-24.
10. Smid M, Galbiati S, Vassallo A, Gambini D, Ferrari A, Viora E, et al. No evidence of fetal DNA persistence in maternal plasma after pregnancy. Hum Genet 2003;112:617-8.
11. Johnson-Hopson CN, Artlett CM. Evidence against the long-term persistence of fetal DNA in maternal plasma after pregnancy. Hum Genet 2002;111:575.
12. Benachi A, Steffann J, Gautier E, Ernault P, Olivi M, Dumez Y, Costa JM. Fetal DNA in maternal serum: Does it persist after pregnancy? Hum Genet 2003;113:76-9.
13. Botezatu I, Serdyuk O, Potapova G, Shelepov V, Alechina R, Molyaka Y, et al. Genetic analysis of DNA excreted in urine: a new approach for detecting specific genomic DNA sequences from cells dying in an organism. Clin Chem 2000;46: 1078-84.
14. Al-Yatama MK, Mustafa AS, Ali S, Abraham S, Khan Z, Khaja N. Detection of Y chromosomespecific DNA in the plasma and urine of pregnant women using nested polymerase chain reaction. Prenat Diagn 2001;21:399-402.
15. Majer S, Bauer M, Magnet E, Strele A, Giegerl E, Eder M, et al. Maternal urine for prenatal diagnosis-an analysis of cell-free fetal DNA in maternal urine and plasma in the third trimester. Prenat Diagn 2007;27:1219-23.
16. Zhong XY, Hahn D, Troeger C, Klemm A, Stein G, Thomson P, et al. Cell-free DNA in urine: a marker for kidney graft rejection, but not for prenatal diagnosis? Ann N Y Acad Sci 2001;945:250-7.
17. Li Y, Zhong XY, Kang A, Troeger C, Holzgreve W, Hahn S. Inability to detect cell free fetal DNA in the urine of normal pregnant women nor in those affected by preeclampsia associated HELLP syndrome. J Soc Gynecol Investig 2003;10:503-8.
18. Illanes S, Denbow ML, Smith RP, Overton TG, Soothill PW, Finning K. Detection of cell-free fetal DNA in maternal urine. Prenat Diagn 2006;26: 1216-8.
19. Tsui NBY, Jiang P, Chow KCK, Su X, Leung TY, Sun H, et al. High resolution size analysis of fetal DNA in the urine of pregnant women by pairedend massively parallel sequencing. PLoS One 2012;7:e48319.
20. Lau TW, Leung TN, Chan LYS, Lau TK, Chan KCA, Tam WH, Lo YMD. Fetal DNA clearance from maternal plasma is impaired in preeclampsia. Clin Chem 2002;48:2141-6.
21. Nelson M, Eagle C, Langshaw M, Popp H, Kronenberg H. Genotyping fetal DNA by non-invasive means: extraction from maternal plasma. Vox Sang 2001;80:112-6.
22. To EWH, Chan KCA, Leung SF, Chan LYS, To KF, Chan ATC, et al. Rapid clearance of plasma Epstein-Barr virus DNA after surgical treatment of nasopharyngeal carcinoma. Clin Cancer Res 2003;9:3254-9.
23. Lo YMD, Leung SF, Chan LYS, Chan ATC, Lo KW, Johnson PJ, Huang DP. Kinetics of plasma Epstein-Barr virus DNA during radiation therapy for nasopharyngeal carcinoma. Cancer Res 2000; 60:2351-5.
24. Chan ATC, Lo YMD, Zee B, Chan LYS, Ma BBY, Leung SF, et al. Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma. J Natl Cancer Inst 2002;94:1614-9.
25. Chiu RWK, Cantor CR, Lo YMD. Non-invasive prenatal diagnosis by single molecule counting technologies. Trends Genet 2009;25:324-31.
26. Lo YMD, Chan KCA, Sun H, Chen EZ, Jiang P, Lun FMF, et al. Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med 2010;2: 61ra91.
27. Tryggvason K. Unraveling the mechanisms of glomerular ultrafiltration: nephrin, a key component of the slit diaphragm. J Am Soc Nephrol 1999; 10:2440-5.
28. Tryggvason K, Wartiovaara J. How does the kidney filter plasma? Physiology 2005;20:96-101.
29. Rippe B, Davies S. Permeability of peritoneal and glomerular capillaries: What are the differences according to pore theory? Perit Dial Int 2011;31: 249-58.
30. Zheng YWL, Chan KCA, Sun H, Jiang P, Su X, Chen EZ, et al. Nonhematopoietically derived DNA is shorter than hematopoietically derived DNA in plasma: a transplantation model. Clin Chem 2012;58:549-58.
31. Hytten F. Blood volume changes in normal pregnancy. Clin Haematol 1985;14:601-12.
32. Chused TM, Steinberg AD, Talal N. The clearance and localization of nucleic acids by New Zealand and normal mice. Clin Exp Immunol 1972;12: 465-76.
33. Lo YMD, Leung TN, Tein MSC, Sargent IL, Zhang J, Lau TK, et al. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem 1999;45:184-8.
34. Ishihara N, Matsuo H, Murakoshi H, Laoag-Fernandez JB, Samoto T, Maruo T. Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol 2002;186:158-66.
35. Chan KCA, Jiang P, Zheng YWL, Liao GJ, Sun H, Wong J, et al. Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing. Clin Chem 2013;59:211-24.
36. Leary RJ, Sausen M, Kinde I, Papadopoulos N, Carpten JD, Craig D, et al. Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing. Sci Transl Med 2012;4:162ra54.
37. Lo YMD, Tein MSC, Pang CCP, Yeung CK, Tong KL, Hjelm NM. Presence of donor-specific DNA in plasma of kidney and liver-transplant recipients. Lancet 1998;351:1329-30.